Rilonacept in Subjects With Cardiac Sarcoidosis
Rilonacept in Subjects With Cardiac Sarcoidosis
Recruiting · NCT06660732 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rilonacept in Subjects With Cardiac Sarcoidosis | Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiac sarcoidosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart failure, myocarditis | Recruiting | Phase 2 | 2026-08-20 | NCT06660732 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| Mayo Clinic | 970 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 60 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |